Biomarin Pharmaceutical Inc at Wedbush PacGrow Healthcare Virtual Conference Transcript
Thank you very much for joining us at the 2020 Virtual Wedbush Healthcare Conference. My name is Liana Moussatos, and I'm one of the senior health care analysts at Wedbush. It's my pleasure to introduce our next presenting company, BioMarin Pharmaceuticals, which is on the Wedbush's Best Ideas List. BioMarin is the first company to develop a one-shot-and-done gene therapy cure for hemophilia A and is years ahead of the competition.
Today, we are joined by the CFO, Brian Mueller; and Chief Commercial Officer, Jeff Ajer. Thanks very much for joining us. We will start with a fireside chat and then transition to Q&A. If you would like to ask a question, please submit them through the chat window at the bottom of your screen.
Questions & Answers
So Brian, Jeff, let's start with ROCTAVIAN for hemophilia A. Can you describe the burden of the disease? And
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
